KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) FCF Margin (2016 - 2025)

Historic FCF Margin for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to 9.98%.

  • Biolife Solutions' FCF Margin fell 72600.0% to 9.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.85%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 6.33% for FY2024, which is 312200.0% up from last year.
  • Per Biolife Solutions' latest filing, its FCF Margin stood at 9.98% for Q3 2025, which was down 72600.0% from 23.61% recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' FCF Margin ranged from a high of 27.71% in Q2 2024 and a low of 33.36% during Q2 2021
  • Moreover, its 5-year median value for FCF Margin was 6.27% (2021), whereas its average is 7.15%.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by -746700bps in 2021, then soared by 562000bps in 2024.
  • Quarter analysis of 5 years shows Biolife Solutions' FCF Margin stood at 6.27% in 2021, then crashed by -32bps to 8.26% in 2022, then plummeted by -162bps to 21.67% in 2023, then soared by 118bps to 3.89% in 2024, then soared by 157bps to 9.98% in 2025.
  • Its FCF Margin stands at 9.98% for Q3 2025, versus 23.61% for Q2 2025 and 4.91% for Q1 2025.